PINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 6.267
NA - Nord America 6.007
AS - Asia 1.028
SA - Sud America 16
AF - Africa 15
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 11
Totale 13.357
Nazione #
US - Stati Uniti d'America 5.986
GB - Regno Unito 1.868
IT - Italia 1.036
IE - Irlanda 988
CN - Cina 684
SE - Svezia 603
UA - Ucraina 524
DE - Germania 343
RU - Federazione Russa 305
FR - Francia 264
FI - Finlandia 129
SG - Singapore 109
VN - Vietnam 92
ES - Italia 69
BE - Belgio 37
PL - Polonia 24
IR - Iran 22
TR - Turchia 22
CZ - Repubblica Ceca 21
CA - Canada 19
IN - India 19
HK - Hong Kong 15
NL - Olanda 15
AU - Australia 11
CI - Costa d'Avorio 11
EU - Europa 11
PK - Pakistan 10
AT - Austria 9
JP - Giappone 8
RO - Romania 8
BR - Brasile 6
IL - Israele 6
PH - Filippine 6
DK - Danimarca 5
PE - Perù 5
JO - Giordania 4
TW - Taiwan 4
AZ - Azerbaigian 3
BD - Bangladesh 3
CL - Cile 3
EG - Egitto 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
RS - Serbia 3
SA - Arabia Saudita 3
EC - Ecuador 2
EE - Estonia 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
MT - Malta 1
MY - Malesia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.357
Città #
Southend 1.771
Dublin 977
Fairfield 783
Chandler 554
Ashburn 478
Siena 462
Jacksonville 430
Woodbridge 403
Ann Arbor 351
Wilmington 325
Seattle 324
Houston 299
Menlo Park 261
Cambridge 247
Princeton 173
Beijing 172
Nanjing 134
Dong Ket 91
Boardman 83
New York 80
Singapore 78
San Mateo 68
Málaga 61
Nanchang 55
Shanghai 52
Helsinki 51
San Diego 51
Florence 48
Dearborn 42
Fremont 42
Shenyang 40
Rome 38
Hebei 35
Brussels 33
Moscow 33
Redwood City 29
Kunming 23
Tianjin 22
Washington 22
Bagno a Ripoli 21
Brno 19
Changsha 19
Milan 19
Los Angeles 18
Jiaxing 17
London 16
Ningbo 16
Izmir 15
Gdansk 14
Chicago 13
Düsseldorf 13
Toronto 13
Dallas 12
Kansas City 12
Phoenix 12
Zhengzhou 12
Abidjan 11
Jinan 11
Arezzo 10
Hangzhou 10
Lancaster 10
San Francisco 10
Norwalk 9
University Park 9
Venezia 9
Vienna 9
Zanjan 9
Guangzhou 8
Tappahannock 8
Auburn Hills 7
Colle Di Val D'elsa 7
Hong Kong 7
Atlanta 6
Lanzhou 6
Nürnberg 6
Santa Clara 6
Stockholm 6
Taizhou 6
Fuzhou 5
Kilburn 5
Leawood 5
Lima 5
Munich 5
Naples 5
Radomsko 5
Waukegan 5
Amman 4
Amsterdam 4
Barcelona 4
Beitou 4
Catania 4
Changchun 4
Como 4
Cosenza 4
Grosseto 4
Hefei 4
Lappeenranta 4
Melbourne 4
Napoli 4
Nuremberg 4
Totale 9.758
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 266
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 255
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 251
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 249
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 228
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 218
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 211
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 206
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 204
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 201
Tumor imaging with tetrabranched neurotensin 199
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 195
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 194
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 193
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 189
A new NT4 peptide-based drug delivery system for cancer treatment 172
Branched peptides for tumor diagnosis and therapy 170
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 170
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 170
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 169
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 166
Branched Neurotensin For Tumor Targeting 166
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 165
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 163
Branched peptides as bioactive molecules for drug design 161
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 161
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 160
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 160
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 158
Synthetic peptides in the form of dendrimers become resistant to protease activity 157
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 154
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 152
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 149
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 148
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 147
Bioactive peptides from libraries 144
Branched peptides as targeting agents for tumor imaging and therapy 144
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 142
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 142
Branched multimeric peptides for tumor diagnosis and therapy 140
Antibacterial peptides and analogues thereof 140
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 139
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 136
Branched neurotensin for tumor targeting 135
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate. 131
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents. 130
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 130
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 129
Molecular basis of branched peptides resistance to enzyme proteolysis 128
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 127
COMPOSTI ANTI TNF-ALPHA E LORO USI 125
Neurotensin-derived branched peptides and uses thereof 124
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 124
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 122
BRANCHED PEPTIDES AS THERAPEUTICS 121
The development of antimicrobial peptides as new antibacterial drugs. 121
Branched Neurotensin peptides for tumor personalized therapy 121
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 120
Synthetic antidotes against snake neurotoxins 120
Tumor imaging with tetrabranched neurotensin 120
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 120
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 118
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 118
The antimicrobial peptide M33. An example of drug development 117
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 116
Tumor selective targeting by branched peptides 114
Phage display and colony filter screening for high-throughput selection of antibody libraries 113
The antimicrobial peptide M33. An example of drug development 113
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 112
TARGETING BY AFFINITY MATURED RECOMBINANT ANTIBODY FRAGMENTS OF AN ANGIOGENESIS ASSOCIATED FIBRONECTIN ISOFORM 109
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 109
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 108
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 106
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 106
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. 105
null 105
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 104
Peptide sequences, their branched form and use thereof for antimicrobial applications 102
Phage display of antibody fragments 99
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 98
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 98
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 97
Branched neurotensin peptides for tumor targeting 95
Synthetic peptides in the form of dendrimers can become resistant to protease activity 92
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 91
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 91
OLIGO-BRANCHED PEPTIDES FOR TUMOR TARGETING: FROM MAGIC BULLETS TO MAGIC FORKS. 88
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 88
Synthetic inhibitors of anthrax lethal toxin 86
null 78
null 75
Dendrimeric peptides for tumor targeting 73
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 68
Peptide Drugs 66
Peptides mimotopes of the nicotinic receptor binding site 64
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 52
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 51
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 48
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 46
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 38
Totale 13.409
Categoria #
all - tutte 41.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.102 0 0 178 359 182 193 208 283 212 240 91 156
2020/20212.378 108 185 48 191 77 333 227 310 206 328 153 212
2021/20221.498 87 157 97 157 95 63 60 81 58 177 171 295
2022/20232.067 115 209 254 280 221 386 53 162 171 88 89 39
2023/20241.603 54 52 132 78 69 449 561 34 8 36 20 110
2024/2025559 74 149 336 0 0 0 0 0 0 0 0 0
Totale 13.594